Creative Medical Technology Holdings, Inc. Debt Instrument, Interest Rate During Period
Creative Medical Technology Holdings, Inc. (CELZ) reported Debt Instrument, Interest Rate During Period of 4.24% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2026-03-20
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for the quarter ending 2025-03-31 was 4.04%, a 398.77% increase year-over-year.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for the quarter ending 2024-03-31 was 0.81%, a 0.00% change year-over-year.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for the quarter ending 2023-03-31 was 0.81%.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for fiscal 2025 was 4.24%, a 0.00% change from fiscal 2024.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for fiscal 2024 was 4.24%, a 423.46% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for fiscal 2023 was 0.81%, a 0.00% change from fiscal 2022.
- Creative Medical Technology Holdings, Inc. debt instrument, interest rate during period for fiscal 2022 was 0.81%.
| Period end | Debt Instrument, Interest Rate During Period 0 month | Debt Instrument, Interest Rate During Period 1 month | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | 4.24% 10-K · filed 2026-03-20 | |||||
| 2025-10-29 | 3.70% 10-K · filed 2026-03-20 | |||||
| 2025-06-30 | 4.04% 10-Q · filed 2025-08-08 | |||||
| 2025-03-31 | 4.04% 10-Q · filed 2025-05-09 | |||||
| 2025-03-06 | 4.04% 10-K · filed 2026-03-20 | |||||
| 2024-12-31 | 4.24% 10-K · filed 2025-03-14 | |||||
| 2024-09-30 | 0.81% 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | 0.81% 10-Q · filed 2024-08-09 | |||||
| 2024-03-31 | 0.81% 10-Q · filed 2024-05-10 | |||||
| 2023-12-31 | 0.81% 10-K · filed 2024-03-22 | |||||
| 2023-09-30 | 0.81% 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 0.81% 10-Q · filed 2023-08-11 | |||||
| 2023-03-31 | 0.81% 10-Q · filed 2023-05-12 | |||||
| 2022-12-31 | 0.81% 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | 0.10% 10-Q · filed 2022-11-10 | |||||
| 2020-02-29 | 8.00% 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |